Alcanza Clinical Research

Alcanza Clinical Research

Private
Lake Mary, FloridaHealthcare & Life Scienceshttps://www.alcanzaclinical.com

Last Round

Growth Equity

Oct 3, 2022

Company Overview

Alcanza Clinical Research is a healthcare company focused on delivering inclusive and impactful medical services through the provision of first-step approved treatments, disease detection, and clinical trials to enhance patient care.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Project Management, Quality Management, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

clinical research site networksite management organizationSMOclinical trial executionpatient recruitmentdiverse patient recruitmentclinical trial diversitymulti-site trialsPhase I-IV trialssite acquisitionresearch site roll-upCRObiopharmaceutical companiesstudy start-updevice trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alcanza Clinical Research Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alcanza Clinical Research Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth EquityOct 3, 2022

Key People

Founding team and executive leadership

Carlos E. Orantes

Chief Executive Officer

Executive Team

Karim C.

President Chief Operating Officer

Executive Team

Alcanza Clinical Research Investors

Notable investors and investment history

InvestorRounds
Twin Bridge Capital PartnersGrowth Equity
ICP GroupGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Expanded network into Arizona with Phoenix Medical Trials.

  • Jan 16, 2026

    Kansas City Research Institute now operates as part of the network.

Alcanza Clinical Research Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alcanza Clinical Research Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alcanza Clinical Research's valuation, stock price, and market status.

Firmographic Details

HeadquartersLake Mary, Florida
Employee Range202
Year Founded2021
Last FundingOct 3, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.